[Use of interferon inducers in treating viral diseases].
The results obtained in the experimental and clinical study of the preparations of mephenamine acid and levamisole with respect to their interferonogenic and interferon-stimulating action and their therapeutic effectiveness in influenza and virus hepatitis are presented. The study has revealed that mephenamine acid, along with its capacity for stimulating the processes of interferon formation in the body, produces a pronounced curative effect, prevents the development of postinfluenza complications much more effectively than levamisole and remantadin and accelerates the processes of reparation in virus hepatitis.
D000293:Adolescent; D000328:Adult; D000818:Animals; D004341:Drug Evaluation; D004353:Drug Evaluation, Preclinical; D006506:Hepatitis A / Q000188:drug therapy; D006509:Hepatitis B / Q000188:drug therapy; D006801:Humans; D007251:Influenza, Human / Q000188:drug therapy; D007369:Interferon Inducers / Q000627:therapeutic use*; D007372:Interferons / Q000097:blood; D007978:Levamisole / Q000627:therapeutic use; D008528:Mefenamic Acid / Q000627:therapeutic use; D051379:Mice; D013997:Time Factors; D014721:Vesicular stomatitis Indiana virus / Q000187:drug effects; D014777:Virus Diseases / Q000188:drug therapy*
D007369:Interferon Inducers; D007978:Levamisole; D008528:Mefenamic Acid; D007372:Interferons
Ispol'zovanie induktorov interferona v lechenii nekotorykh virusnykh zabolevaniĭ.